[Form 4] MoonLake Immunotherapeutics Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MoonLake Immunotherapeutics received an updated ownership report from a group of BVF-related investment funds and Mark N. Lampert, who together form a Section 13(d) group holding more than 10% of the company’s common stock. The filing mainly records existing Class A Ordinary Share positions and a new stock option award linked to director Spike Loy’s service. The option covers 22,195 Class A Ordinary Shares at an exercise price of $19.19 per share, expiring on June 17, 2036, and vests in full on the earlier of June 17, 2027 or the next annual general meeting of shareholders, subject to his continued service. The group and Mr. Loy each disclaim beneficial ownership beyond their economic interests.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Role
null | null | null | null | null | null | null | null | null | null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Buy | 22,195 | $0.00 | -- |
| holding | Option to Buy | -- | -- | -- |
| holding | Option to Buy | -- | -- | -- |
| holding | Option to Buy | -- | -- | -- |
| holding | Class A Ordinary Shares, $0.0001 par value | -- | -- | -- |
| holding | Class A Ordinary Shares, $0.0001 par value | -- | -- | -- |
| holding | Class A Ordinary Shares, $0.0001 par value | -- | -- | -- |
Holdings After Transaction:
Option to Buy — 22,195 shares (Indirect, See footnote);
Class A Ordinary Shares, $0.0001 par value — 8,302,735 shares (Direct, null)
Footnotes (1)
- This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF I GP LLC ("BVF GP"), BVF II GP LLC ("BVF2 GP"), BVF GP Holdings LLC ("BVF GPH"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Securities owned directly by BVF. As the general partner of BVF, BVF GP may be deemed to beneficially own the securities owned directly by BVF. As the sole member of BVF GP, BVF GPH may be deemed to beneficially own the securities owned directly by BVF. As the investment manager of BVF, Partners may be deemed to beneficially own the securities owned directly by BVF. As the general parter of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF. Securities owned directly by BVF2. As the general partner of BVF2, BVF2 GP may be deemed to beneficially own the securities owned directly by BVF2. As the sole member of BVF2 GP, BVF GPH may be deemed to beneficially own the securities owned directly by BVF2. As the investment manager of BVF2, Partners may be deemed to beneficially own the securities owned directly by BVF2. As the general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF2. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF2. Securities owned directly by Trading Fund OS. As the general partner of Trading Fund OS, Partners OS may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the investment manager of Trading Fund OS and the sole member of Partners OS, Partners may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by Trading Fund OS. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by Trading Fund OS. This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to Spike Loy's continued service to the Issuer. This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer. This option has fully vested as of the date hereof. This option represents a right to purchase a total of 7,688 Class A Ordinary Shares of the Issuer. This option has fully vested as of the date hereof. This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer. This option has fully vested as of the date hereof. Partners, BVF Inc. and Mr. Lampert may be deemed to have a pecuniary interest in the securities reported owned herein due to a certain agreement between Partners and Spike Loy, who serves on the Issuer's board of directors and as a Managing Director of Partners, pursuant to which Mr. Loy is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the securities reported owned herein to Partners. As such, Mr. Loy disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
Key Figures
New option grant size: 22,195 shares
New option exercise price: $19.19 per share
Existing option 1: 11,297 shares at $29.18
+5 more
8 metrics
New option grant size
22,195 shares
Class A Ordinary Shares underlying new option award
New option exercise price
$19.19 per share
Exercise price for 22,195-share option expiring June 17, 2036
Existing option 1
11,297 shares at $29.18
Fully vested option to buy Class A Ordinary Shares, expires June 8, 2033
Existing option 2
7,688 shares at $42.44
Fully vested option to buy Class A Ordinary Shares, expires June 6, 2034
Existing option 3
6,682 shares at $48.83
Fully vested option to buy Class A Ordinary Shares, expires June 5, 2035
Direct holding entry 1
1,039,238 shares
Class A Ordinary Shares directly owned in one BVF-related account
Direct holding entry 2
6,599,722 shares
Class A Ordinary Shares directly owned in another BVF-related account
Direct holding entry 3
8,302,735 shares
Class A Ordinary Shares directly owned in a third BVF-related account
Key Terms
Section 13(d) group, pecuniary interest, Class A Ordinary Shares, Option to Buy, +1 more
5 terms
Section 13(d) group regulatory
"Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10%..."
pecuniary interest financial
"Each of the Reporting Persons disclaims beneficial ownership... except to the extent of his or its pecuniary interest therein."
Option to Buy financial
"This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer."
